Concepedia
Statistics
Publications
26
Citations
2.2K
H-Index
19
Active since
1989
Affiliations
Pfizer (United States)(Current)
University of Michigan
Warner University
Warde Medical Laboratory
Amgen (United States)
Edward L. Posvar is an author at Pfizer (United States) specializing in pharmacokinetics, pharmacology, and clinical pharmacology.
Publications per year
1989–2012
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
Desmond Padhi, Graham Jang, Brian Stouch et al. · Journal of Bone and Mineral Research · 2010 · 783 citations
Pharmacy, Pharmacokinetics, Pharmacotherapy +17
Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function
Edward J. Randinitis, Edward L. Posvar, Christine Alvey et al. · The Journal of Clinical Pharmacology · 2003 · 257 citations
Pharmacy, Pharmacokinetics, Pharmacology +16
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects
Donald D. Cilla, Lloyd R. Whitfield, Donald M. Gibson et al. · Clinical Pharmacology & Therapeutics · 1996 · 204 citations
Pharmacy, Pharmacokinetics, Pharmacology +14
Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers
Howard N. Bockbrader, Louis L. Radulovic, Edward L. Posvar et al. · The Journal of Clinical Pharmacology · 2010 · 186 citations
Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14
Pregabalin Drug Interaction Studies: Lack of Effect on the Pharmacokinetics of Carbamazepine, Phenytoin, Lamotrigine, and Valproate in Patients with Partial Epilepsy
Martin J. Brodie, Elaine A. Wilson, David Wesche et al. · Epilepsia · 2005 · 124 citations
Medicine, Pharmacology, Pharmacotherapy +14
1–5 of 26